Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
9.82Last Year’s EPS
6.18Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 05, 2025
|% Change Since: -0.56%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant revenue and profit growth, driven by strategic acquisitions and expansions in specialty services. Despite challenges in the Medical Surgical segment and some revenue impacts due to formulary changes, the company's raised guidance and strong segment growth indicate a positive outlook.Company Guidance
During McKesson's third-quarter fiscal 2025 earnings call, the company reported strong financial performance with an 18% increase in revenue to $95.3 billion and a 16% rise in adjusted operating profit to $1.5 billion. U.S. pharmaceutical and prescription technology solutions segments led the double-digit growth, while medical surgical growth lagged due to a softer illness season. The company updated its full-year guidance for adjusted earnings per diluted share to a range of $32.55 to $32.95, representing a 19% to 20% year-over-year increase. McKesson also announced the acquisition of a controlling interest in PRISM Vision to enhance its specialty services, contributing to a projected $0.20 to $0.30 accretion to adjusted earnings per diluted share in the first 12 months post-closing. The company remains confident in its strategic growth pillars, including oncology and biopharma services, and anticipates continued strong performance into fiscal 2026, with an affirmed long-term adjusted EPS target growth of 12% to 14%.Strong Revenue and Operating Profit Growth
Revenue grew 18% to $95.3 billion and adjusted operating profit increased 16% to $1.5 billion. Double-digit growth was observed across the U.S. Pharmaceutical and Prescription Technology Solutions segments.
Raised Full-Year Guidance
The full-year guidance for adjusted earnings per diluted share was raised from $32.40-$33 to $32.55-$32.95, representing 19% to 20% year-over-year adjusted EPS growth.
Expansion in Specialty Services
McKesson announced the acquisition of a controlling interest in PRISM Vision, a provider of ophthalmology and retina management services. This acquisition is expected to be accretive to EPS by $0.20 to $0.30 in the first 12 months post-closing.
Growth in Oncology and Biopharma Services
The oncology platform expanded with 2,750 providers across 640 sites of care. Prescription Technology Solutions segment saw 14% revenue growth and 22% operating profit growth, driven by access and affordability solutions.
---
MCK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MCK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 05, 2025 | $606.90 | $599.75 | -1.18% |
| Nov 06, 2024 | $548.69 | $606.82 | +10.59% |
| Aug 07, 2024 | $616.02 | $546.19 | -11.34% |
| May 07, 2024 | $543.84 | $541.71 | -0.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Mckesson Corp. (MCK) report earnings?
Mckesson Corp. (MCK) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Mckesson Corp. (MCK) earnings time?
Mckesson Corp. (MCK) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MCK EPS forecast?
MCK EPS forecast for the fiscal quarter 2025 (Q4) is 9.82.
---